Artificial Intelligence (AI) in Precision Medicine Market Report and Forecast 2025-2034
Market Report I 2025-07-29 I 350 Pages I EMR Inc.
The global artificial intelligence (AI) in precision medicine market size was valued at USD 1.63 Billion in 2024, driven by high demand of precision medicines and rising expenditure on artificial intelligence research and development. The market is expected to grow at a CAGR of 35.60% during the forecast period of 2025-2034, with the values likely to rise from to USD 34.26 Billion by 2034.
Artificial Intelligence (AI) in Precision Medicine: Introduction
Precision medicine is offering a customized drug or treatment to a patient based on the genetic or molecular understanding of their disease. The approach behind precision medicine is that each patient has a unique set of symptoms which may not necessarily be like others, even though they are suffering from the same disease.
Artificial intelligence and precision medicine convergence is set to revolutionize the future of healthcare industry. Artificial intelligence is expected to help with personalised diagnostics, treatment, and prevention. It will leverage inference and computation to generate valuable insights, empowering it to learn and reason to make clinically sound decisions.
Global Artificial Intelligence (AI) in Precision Medicine Market Analysis
The world has witnessed vast applications of artificial intelligence in almost every major field in the past few years. A similar trend has been followed in the medicine and healthcare industry as well. With the sudden outbreak of COVID-19, there has been a prominent use of artificial intelligence in the hospitals in the form of pharmacy automation devices, vitals monitoring devices and reducing the load of labour-intensive and repetitive tasks, improving the productivity of the healthcare staff significantly.
Artificial intelligence is an integral part of early-stage drug development case studies. There has been valuable development in 3D bioprinters, which now work on the mechanism of machine learning. This has allowed machines to optimise the printing process and improve accuracy as well. As a result, there has been significant artificial intelligence (AI) in precision medicine market growth. The trend is set to grow as the global health ecosystem leans towards usage of precision medicine for treatments.
There is an increasing emphasis on leveraging artificial intelligence to make drug discovery faster and economical. With the emergence of algorithms and machine learning, healthcare data analysis can become accurate and rapid. Empowered by predictive models, artificial intelligence can be used to cut-down long hours of lab work by predicting how potential drugs may behave in the body leading to precise diagnosis and development of personalised treatment plans. With further ideations and developments, the artificial intelligence (AI) in precision medicine market value is predicted to grow further in the upcoming years.
Global Artificial Intelligence (AI) in Precision Medicine Market Segmentation
Artificial Intelligence (AI) in Precision Medicine Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Medicine Market Breakup by Type
- Machine Learning
- Querying Method
- Deep Learning
- Context-Aware Processing
- Natural Language Processing
Market Breakup by Components
- Hardware
- Software
Market Breakup by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Artificial Intelligence (AI) in Precision Medicine Market Overview
With a robust research and development infrastructure and hefty investments coming in from major corporations and the government, the United States owns the largest artificial intelligence (AI) in precision medicine market share.
In March 2024, Google Cloud launched two new AI powered tools with a vision to help biotech companies speed up the drug discovery process and dive deeper into artificial intelligence driven precision medicine. "Target and Lead Identification Suite" is the first tool that helps in identification of the biological target, helping the researchers design a treatment around it while the second tool is called "Multiomics Suite" helps with genomic data analysis.
Dartmouth has also launched a special centre for precision health and artificial intelligence with the aim to help scientists research into the field deeply. Such steps in the field of precision medicine indicate a profound market expansion in the future.
We can also expect to see the dramatic rise of Asia Pacific led research in the precision medicine domain. This can be attributed to extensive development in biotech industry, with the added boost of several government grants and foreign investments.
Global Artificial Intelligence in Precision Medicine Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Novo Nordisk A/S
- GE Healthcare
- Intel Corporation
- NVIDIA Corporation
- Microsoft Corporation
- Alphabet Inc.
- IBM Corporation
- Enlitic Inc.
- AstraZeneca
- Sanofi
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Artificial Intelligence in Precision Medicine Market Overview
3.1 Global Artificial Intelligence in Precision Medicine Market Historical Value (2018-2024)
3.2 Global Artificial Intelligence in Precision Medicine Market Forecast Value (2025-2034)
4 Global Artificial Intelligence in Precision Medicine Market Landscape
4.1 Artificial Intelligence in Precision: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Artificial Intelligence in Precision: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Components
4.2.3 Analysis by Region
5 Global Artificial Intelligence in Precision Medicine Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Artificial Intelligence in Precision Medicine Market Segmentation
6.1 Global Artificial Intelligence in Precision Medicine Market by Type
6.1.1 Market Overview
6.1.2 Machine Learning
6.1.3 Querying Method
6.1.4 Deep Learning
6.1.5 Context-Aware Processing
6.1.6 Natural Language Processing
6.2 Global Artificial Intelligence in Precision Medicine Market by Components
6.2.1 Market Overview
6.2.2 Hardware
6.2.3 Software
6.3 Global Artificial Intelligence in Precision Medicine Market by Therapeutic Area
6.3.1 Market Overview
6.3.2 Oncology
6.3.3 Neurology
6.3.4 Cardiology
6.3.5 Respiratory
6.3.6 Others
6.4 Global Artificial Intelligence in Precision Medicine Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Artificial Intelligence in Precision Medicine Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Artificial Intelligence in Precision Medicine Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Artificial Intelligence in Precision Medicine Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Artificial Intelligence in Precision Medicine Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Artificial Intelligence in Precision Medicine Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Novo Nordisk A/S
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 GE Healthcare
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Intel Corporation
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 NVIDIA Corporation
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Microsoft Corporation
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Alphabet Inc.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 IBM Corporation
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Enlitic Inc.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 AstraZeneca
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Sanofi
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.